This company has been marked as potentially delisted and may not be actively trading. Gracell Biotechnologies (GRCL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock GRCL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period GRCL Mar 2024 10.000 call(CONTRMarch 2, 2024 | finance.yahoo.com49,158 Shares in Gracell Biotechnologies Inc. (NASDAQ:GRCL) Purchased by Pathstone Family Office LLCFebruary 24, 2024 | marketbeat.comGracell Biotechnologies Acquisition CompletedFebruary 22, 2024 | finance.yahoo.comGracell Biotechnologies (NASDAQ:GRCL) Given Hold Rating at Stifel NicolausFebruary 22, 2024 | marketbeat.comGracell Biotechnologies Acquisition CompletedFebruary 22, 2024 | globenewswire.comGracell Biotechnologies (Nasdaq:GRCL) HeadlineTrading was temporarily halted for "GRCL" at 07:02 PM with a stated reason of "News pending."...February 22, 2024 | marketbeat.comBarclays PLC Increases Stake in Gracell Biotechnologies Inc. (NASDAQ:GRCL)February 22, 2024 | marketbeat.comAstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)February 21, 2024 | seekingalpha.comGracell Biotechnologies Inc. (GRCL)February 21, 2024 | investing.comStock Traders Buy High Volume of Gracell Biotechnologies Put Options (NASDAQ:GRCL)February 20, 2024 | marketbeat.comGracell Biotechnologies Inc.: Gracell Biotechnologies Announces Shareholders' Approval of Merger AgreementFebruary 20, 2024 | finanznachrichten.deGracell Biotechnologies Announces Shareholders’ Approval of Merger AgreementFebruary 20, 2024 | finance.yahoo.comGracell Biotechnologies Announces Shareholders' Approval of Merger AgreementFebruary 20, 2024 | globenewswire.comGRCL Mar 2024 2.500 callFebruary 17, 2024 | finance.yahoo.comGRCL Gracell Biotechnologies Inc.February 17, 2024 | seekingalpha.comGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Rating of "Moderate Buy" by BrokeragesFebruary 10, 2024 | marketbeat.comGracell Biotechnologies (NASDAQ:GRCL) Sets New 12-Month High at $10.36February 9, 2024 | marketbeat.comGracell Biotechnologies Inc. (NASDAQ:GRCL) is Vivo Capital LLC's 9th Largest PositionFebruary 6, 2024 | marketbeat.comGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple MyelomaJanuary 29, 2024 | finance.yahoo.comAstraZeneca: Rebound in 2024 with double-digit earnings growth (GRCL)AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition...January 11, 2024 | marketbeat.comGracell Biotechnologies Inc. Sponsored ADR (GRCL) is a Great Momentum Stock: Should You Buy?January 3, 2024 | finance.yahoo.comGRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...December 31, 2023 | businesswire.comBarclays PLC Trims Stock Position in Gracell Biotechnologies Inc. (NASDAQ:GRCL)December 30, 2023 | marketbeat.comGracell Biotechnologies Inc. to Post FY2026 Earnings of ($0.82) Per Share, HC Wainwright Forecasts (NASDAQ:GRCL)December 29, 2023 | marketbeat.comGracell Biotechnologies (NASDAQ:GRCL) Earns "Equal Weight" Rating from Wells Fargo & CompanyDecember 27, 2023 | marketbeat.comMaintaining Hold on Gracell Biotechnologies Amidst AstraZeneca Acquisition ProspectsDecember 27, 2023 | markets.businessinsider.comWhy China-Based Gracell Biotechnologies (GRCL) Stock Is Soaring TodayDecember 26, 2023 | msn.comGracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseasesDecember 26, 2023 | finance.yahoo.comGracell Biotechnologies (NASDAQ:GRCL) Stock Rating Reaffirmed by BTIG ResearchDecember 26, 2023 | marketbeat.comGracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market SessionDecember 26, 2023 | markets.businessinsider.comGRCL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Gracell Biotechnologies Inc. Is Fair to ShareholdersDecember 26, 2023 | tmcnet.comGracell Biotechnologies Inc. (NASDAQ:GRCL) Given Average Recommendation of "Buy" by BrokeragesDecember 22, 2023 | marketbeat.comGracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus ErythematosusDecember 21, 2023 | finance.yahoo.comGracell Biotechnologies Inc. Sponsored ADR (GRCL) Is a Great Choice for 'Trend' Investors, Here's WhyDecember 21, 2023 | finance.yahoo.comPivotal bioVenture Partners Investment Advisor LLC Invests $3.96 Million in Gracell Biotechnologies Inc. (NASDAQ:GRCL)December 18, 2023 | marketbeat.comGracell Biotechnologies Inc. (NASDAQ:GRCL) Short Interest UpdateDecember 16, 2023 | marketbeat.comGracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023December 11, 2023 | finance.yahoo.comWall Street Analysts Believe Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Could Rally 127.82%: Here's is How to TradeDecember 11, 2023 | finance.yahoo.comInstitutions own 19% of Gracell Biotechnologies Inc. (NASDAQ:GRCL) shares but private equity firms control 45% of the companyDecember 2, 2023 | finance.yahoo.comBuy Rating for Gracell Biotechnologies on Promising CAR-T Cell Therapy AdvancementsNovember 29, 2023 | markets.businessinsider.comEvercore ISI Group Initiates Coverage of Gracell Biotechnologies Inc - ADR (GRCL) with Outperform RecommendationNovember 28, 2023 | msn.comGracell Biotechnologies Shares Rise 9%, FDA Clears Application for Lupus TreatmentNovember 27, 2023 | marketwatch.comGracell Biotechnologies: FDA Clears IND Application For Phase 1/2 Trial Of FasTCAR-T GC012FNovember 27, 2023 | markets.businessinsider.comGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus ErythematosusNovember 27, 2023 | finance.yahoo.comWhat Makes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) a Strong Momentum Stock: Buy Now?November 23, 2023 | finance.yahoo.comDoes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Have the Potential to Rally 120.94% as Wall Street Analysts Expect?November 23, 2023 | finance.yahoo.comGracell Biotechnologies Inc.: Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease SummitNovember 16, 2023 | finanznachrichten.deGracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease SummitNovember 16, 2023 | finance.yahoo.comPositive Outlook for Gracell Biotechnologies: Promising Translational Data and Financial Stability Backs Buy RatingNovember 14, 2023 | markets.businessinsider.comGracell Biotechnologies: Promising Developments in Systemic Lupus Erythematosus Treatment Augment Buy RatingNovember 14, 2023 | markets.businessinsider.com Get Gracell Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter. Email Address GRCL Media Mentions By Week GRCL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRCL News Sentiment▼0.000.54▲Average Medical News Sentiment GRCL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRCL Articles This Week▼00▲GRCL Articles Average Week Get Gracell Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHXM News SXTPW News DRTSW News BCTXW News ENGNW News FBIOP News GOVXW News LEXXW News NTRBW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRCL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gracell Biotechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gracell Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
